Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CRISPR01:59

CRISPR

57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
Epigenetic Regulation01:46

Epigenetic Regulation

33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation01:37

Epigenetic Regulation

3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
RNA Editing02:23

RNA Editing

9.7K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.7K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
What is Genetic Engineering?00:49

What is Genetic Engineering?

79.6K
Overview
79.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-throughput measurements of protein domain functions using magnetic separation.

Nature protocols·2026
Same author

Neuron-specific epigenetic repression of <i>Cdk5</i> impairs hippocampal-dependent memory in male and female mice.

bioRxiv : the preprint server for biology·2026
Same author

Hippocampal estrogen levels, receptor types, and epigenetics contribute to sex-specific memory vulnerabilities to concurrent acute stresses.

Neuron·2026
Same author

Structural probing of RNA hairpins quantifies protein occupancy on RNA and links it to function in human cells.

bioRxiv : the preprint server for biology·2026
Same author

Hippocampal Cdk5 is regulated by distinct stress paradigms in male and female mice.

bioRxiv : the preprint server for biology·2026
Same author

Bifunctional transcriptional effector domains control gene expression pulses in an occupancy-dependent manner.

bioRxiv : the preprint server for biology·2025

相关实验视频

Updated: Jan 10, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.2K

表观遗传编辑:从概念到临床

Elizabeth A Heller1, Lacramioara Bintu2, Marianne G Rots3

  • 1Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.

Nature reviews. Drug discovery
|November 25, 2025
PubMed
概括

表观遗传编辑通过重新编程基因表达而不会改变基因组,提供了一种新的治疗方法. 尽管存在早期的挑战,但正在进行的研究正在提高其治疗疾病的有效性和特异性.

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.3K
Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
09:56

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

Published on: October 31, 2025

359

相关实验视频

Last Updated: Jan 10, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.2K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.3K
Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
09:56

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

Published on: October 31, 2025

359

科学领域:

  • 生物化学 生物化学
  • 遗传学 是一个遗传学.
  • 分子生物学分子生物学

背景情况:

  • 失调的基因表达是大多数人类疾病的基础.
  • 表观遗传修饰是基因表达的关键媒介.
  • 表观遗传编辑为调节基因表达提供了一种方法,而无需基因组改变.

研究的目的:

  • 审查表观遗传编辑方面的进展和挑战.
  • 突出表观遗传编辑的治疗潜力.
  • 讨论进步表观遗传编辑技术的未来方向.

主要方法:

  • 审查关于表观遗传编辑的现有文献.
  • 分析动物模型和早期临床试验的成功情况.
  • 讨论机械学理解和技术进步.

主要成果:

  • 表观遗传编辑在各种疾病的动物模型中显示出有前途.
  • 对表观遗传编辑的第一个临床试验已经开始.
  • 对表观遗传重编程的理解越来越大,正在解决最初的疗效和特异性问题.

结论:

  • 表观遗传编辑正在演变为一种强大的治疗策略.
  • 克服特异性,维护和交付方面的挑战对于广泛应用至关重要.
  • 未来的进展将巩固表观遗传编辑作为一种强大的治疗方法.